SCHEMBL10662

SCHEMBL10662

c1cnc2ccoc2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29446630 1.00
SCHEMBL28156542 0.98 KDM4E (0.41)
SCHEMBL15019884 0.98 KDM4E (0.41)
SCHEMBL28544882 0.88 KDM4E (0.34)
Hydrochlorthiazide SCHEMBL27805829 0.82 KDM4E (0.31)
Benzothiophene SCHEMBL28264756 0.79 ALDH1A1 (0.38)
SCHEMBL10921694 0.78 ALDH1A1 (0.38)
SCHEMBL5802653 0.78 CHRNB2 (0.35)
Quinoline SCHEMBL2826037 0.76 ALDH1A1 (0.63)
Quinoline SCHEMBL28210481 0.74 ALDH1A1 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6797 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3185329-B1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2026-04-22 EP claimed
EP-4482583-B1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2026-04-01 EP claimed
EP-4398698-B1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2026-02-18 EP claimed
EP-3623372-B1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS VALO HEALTH INC (US) 2026-02-04 EP claimed
US-12528822-B2 Cycloalkane-1,3-diamine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2026-01-20 US claimed
US-12523648-B1 Fluorescent indicators for calcium metal ion detection ION Biosciences (US) 2026-01-13 US claimed
US-20250353841-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE HUFF SARAH ELIZABETH (US) 2025-11-20 US claimed
EP-4611899-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-09-10 EP claimed
US-12336991-B2 Factor XIIA inhibitors UNIVERSITY OF LEEDS (GB) 2025-06-24 US claimed
US-20250179066-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2025-06-05 US claimed
EP-0650961-A1 Substituted heterocyclic carboxylic acid amides, their preparation, and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1995-05-03 EP claimed
EP-0124377-B1 CHROMOGENIC COMPOUNDS YAMAMOTO KAGAKU GOSEI CO., LTD. (JP) 1991-09-25 EP claimed
EP-0178201-B1 Furo[3,2-c]pyridine derivatives, their preparation and their therapeutical use SYNTHELABO (FR) 1989-02-01 EP claimed
EP-0178201-A1 Furo[3,2-c]pyridine derivatives, their preparation and their therapeutical use SYNTHELABO (FR) 1986-04-16 EP claimed
US-4577014-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1986-03-18 US claimed
US-4501739-A BACTERICIDES, ANTIBIOTICS ELI LILLY AND COMPANY (US) 1985-02-26 US claimed
EP-0123998-A2 4-Phenyl-tetrahydro-furano-pyridines, process for their preparation and pharmaceutical compositions BOEHRINGER INGELHEIM KG (DE) 1984-11-07 EP claimed
EP-0124377-A2 Chromogenic compounds YAMAMOTO KAGAKU GOSEI CO., LTD. (JP) 1984-11-07 EP claimed
US-4406898-A ANTIBIOTICS CONTAINING A THIENOPYRIDINIUM OR FUROPYRIDINIUM GROUP ELI LILLY AND COMPANY (US) 1983-09-27 US claimed
EP-0074268-A2 Improvements in or relating to thieno and furopyridinium-substituted cephalosporin derivatives ELI LILLY AND COMPANY (US) 1983-03-16 EP claimed